Candriam SCA’s Vericel Corp VCEL Stock Holding History

Candriam SCA’s Portfolio VCEL Stock Details VCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-35,941	Closed	-$1.07M	–	941
2021 Q1	$1.07M	Hold	35,941	–	–	0.01%	621
2020 Q4	$1.11M	Buy	+35,941	New	+$855K	0.01%	633

Other funds holding VCEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Candriam SCA's VCEL Position: Q2 2021 in Review

Candriam SCA sold out of Vericel Corp (VCEL) in Q2 2021, closing a stake of 35,941 shares — an estimated $1.07M sold.

Candriam SCA first reported a position in VCEL in Q4 2020 and held it in 2 quarters. The position peaked at $1.11M in Q4 2020. 205 funds tracked by Wall St. Rank hold VCEL as of Q2 2021.

Candriam SCA reported no remaining Vericel Corp position as of Q2 2021 after selling out during the quarter.
Candriam SCA sold 35,941 Vericel Corp shares in Q2 2021, an estimated $1.07M.
Candriam SCA first reported a position in Vericel Corp in Q4 2020 and held it in 2 quarters.
Candriam SCA's Vericel Corp position peaked at $1.11M in Q4 2020.
205 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2021.

Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.